Health: Teen Suicide Pills?

An FDA panel calls for tough labels on antidepressants. What it means for you

THE QUESTION OF HOW to treat depression in children and teenagers--one of the toughest a parent can face--is back in the news. After an emotional two-day public hearing, a panel of experts last week advised the Food and Drug Administration to require strong warning labels on antidepressant medications. The source of their concern: a number of scientific studies and anecdotal reports that have surfaced over the past year showing that severely depressed youngsters who take the drugs may be at increased risk of suicidal thoughts and behavior. If the proposed warning labels prompt closer monitoring of children who are being treated...

Want the full story?

Subscribe Now


Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!